UBS Group AG

SEC CIK: 0001610520
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

PLYX holding history

Polaryx Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PLYX overview All 13F holders of PLYX Full Q2 2026 holdings

Shares (Q2 2026): 1,283
Value: $3.41K
% of portfolio: <0.1%
Quarters held: 2; Since Q1 2026

Holdings of PLYX by UBS Group AG, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	1,283	$3.41K	<0.1%	−12,196−90.5%	Reduced	Holders
Q1 2026	13,479	$101.9K	<0.1%	+13,479	New	Holders